Home > For Consumers > Reduced dietary salt for the prevention...

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2003-. doi: 10.1002/14651858.CD009217.pub3

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet].

Reduced dietary salt for the prevention of cardiovascular disease

This version published: 2017; Review content assessed as up-to-date: May 01, 2013.

Link to full article: [Cochrane Library]

Plain language summary

Cardiovascular disease includes heart attacks and strokes and is a major cause of premature death and disability. This is an update of a review first published in 2011. This review sets out to assess whether intensive support and encouragement to cut down on salt in foods, and substituting low‐sodium salt, reduces the risk of death or cardiovascular disease. This update includes two new studies and eliminates one problematic study, giving a total of eight trials with 7284 participants.

Dietary advice and salt substitution did reduce the amount of salt eaten, which led to a small reduction in blood pressure by six months. There was weak evidence of benefit for cardiovascular events, but these findings were inconclusive and were driven by a single trial among retirement home residents, which reduced salt intake in the kitchens of the homes.

The findings of our review do not mean that advising people to reduce salt should be stopped. However, additional measures ‐ reducing the amount of hidden salt in processed foods, for example – will make it much easier for people to achieve a lower salt diet. Overall many of the trials failed to report sufficient detail to assess their potential risk of bias. Further evidence of the effects of different ways of reducing dietary salt on clinical events is needed from experimental and observational studies to underpin public health policies.


Background: This is an update of a Cochrane review that was first published in 2011 of the effects of reducing dietary salt intake, through advice to reduce salt intake or low‐sodium salt substitution, on mortality and cardiovascular events.

Objectives: 1. To assess the long‐term effects of advice and salt substitution, aimed at reducing dietary salt, on mortality and cardiovascular morbidity.

2. To investigate whether a reduction in blood pressure is an explanatory factor in the effect of such dietary interventions on mortality and cardiovascular outcomes.

Search methods: We updated the searches of CENTRAL (2013, Issue 4), MEDLINE (OVID, 1946 to April week 3 2013), EMBASE (OVID, 1947 to 30 April 2013) and CINAHL (EBSCO, inception to 1 April 2013) and last ran these on 1 May 2013. We also checked the references of included studies and reviews. We applied no language restrictions.

Selection criteria: Trials fulfilled the following criteria: (1) randomised, with follow‐up of at least six months, (2) the intervention was reduced dietary salt (through advice to reduce salt intake or low‐sodium salt substitution), (3) participants were adults and (4) mortality or cardiovascular morbidity data were available. Two review authors independently assessed whether studies met these criteria.

Data collection and analysis: A single author extracted data and assessed study validity, and a second author checked this. We contacted trial authors where possible to obtain missing information. We extracted events and calculated risk ratios (RRs) and 95% confidence intervals (CIs).

Main results: Eight studies met the inclusion criteria: three in normotensives (n = 3518) and five in hypertensives or mixed populations of normo‐ and hypertensives (n = 3766). End of trial follow‐up ranged from six to 36 months and the longest observational follow‐up (after trial end) was 12.7 years.

The risk ratios (RR) for all‐cause mortality in normotensives were imprecise and showed no evidence of reduction (end of trial RR 0.67, 95% confidence interval (CI) 0.40 to 1.12, 60 deaths; longest follow‐up RR 0.90, 95% CI 0.58 to 1.40, 79 deaths n=3518) or in hypertensives (end of trial RR 1.00, 95% CI 0.86 to 1.15, 565 deaths; longest follow‐up RR 0.99, 95% CI 0.87 to 1.14, 674 deaths n=3085). 

There was weak evidence of benefit for cardiovascular mortality (hypertensives: end of trial RR 0.67, 95% CI 0.45 to 1.01, 106 events n=2656) and for cardiovascular events (hypertensives: end of trial RR 0.76, 95% CI 0.57 to 1.01, 194 events, four studies, n = 3397; normotensives: at longest follow‐up RR 0.84, 95% CI 0.64 to 1.10, 200 events; hypertensives: RR 0.77, 95% CI 0.58 to 1.02, 192 events; pooled analysis of six trials (RR 0.81, 95% CI 0.66 to 0.98; n = 5762). These findings were driven by one trial among retirement home residents that reduced salt intake in the kitchens of the homes, thereby not requiring individual behaviour change.

Advice to reduce salt showed small reductions in systolic blood pressure (mean difference (MD) ‐1.15 mmHg, 95% CI ‐2.32 to 0.02 n=2079) and diastolic blood pressure (MD ‐0.80 mmHg, 95% CI ‐1.37 to ‐0.23 n=2079) in normotensives and greater reductions in systolic blood pressure in hypertensives (MD ‐4.14 mmHg, 95% CI ‐5.84 to ‐2.43 n=675), but no difference in diastolic blood pressure (MD ‐3.74 mmHg, 95% CI ‐8.41 to 0.93 n=675).

Overall many of the trials failed to report sufficient detail to assess their potential risk of bias. Health‐related quality of life was assessed in one trial in normotensives, which reported significant improvements in well‐being but no data were presented.

Authors' conclusions: Despite collating more event data than previous systematic reviews of randomised controlled trials, there is insufficient power to confirm clinically important effects of dietary advice and salt substitution on cardiovascular mortality in normotensive or hypertensive populations. Our estimates of the clinical benefits from advice to reduce dietary salt are imprecise, but are larger than would be predicted from the small blood pressure reductions achieved. Further well‐powered studies would be needed to obtain more precise estimates. Our findings do not support individual dietary advice as a means of restricting salt intake. It is possible that alternative strategies that do not require individual behaviour change may be effective and merit further trials.

Editorial Group: Cochrane Heart Group.

Publication status: Edited (no change to conclusions), comment added to review.

Citation: Adler AJ, Taylor F, Martin N, Gottlieb S, Taylor RS, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No.: CD009217. DOI: 10.1002/14651858.CD009217.pub3. Link to Cochrane Library. [PubMed: 25519688]

Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PMID: 25519688


PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...